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Question 
Can Triple Chronotherapy (TCT) effectively reduce an 
individual’s level of depression and sufficiently stimulate one or 
more positive emotional response? 
Background 
• Unipolar depression has a serious negative impact on a 
person’s quality of life and is associated with increased risk of 
suicide.  
• Although evidence-based treatments for the management of 
depression exist, social stigma, misperceptions of effectiveness 
in self-sustained management, and side effects to antidepressant 
medication all pose treatment barriers. 
• One treatment option that has worked around these barriers 
(TCT) simultaneously employs a therapeutic manipulation of 
sleep-wake cycles and bright light therapy. 
Methods 
Inclusion Criteria 
• Adults with moderate to severe unipolar depression 
• Have resided in Montana for entire adult life 
Intervention 
• Prior to beginning the TCT intervention, participants will be 
evaluated by their levels of depression and positive circuit 
stimulation in brain activity. 
• These measurements will persist through duration and follow 
up of treatment and be compared to levels at onset.  
• A sample of control participants within the same population 
receiving standard care will be compared to the intervention 
group at subsequent time periods. 
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• Suicide rates have steadily increased over the past twenty years 
in the United States with even greater increases in Montana, a 
state with one of the highest rates of suicide. 
 
• Due to Montana’s elevated, vast, rural geographic setting and 
the inability to control for long, dark winters, individuals are 
susceptible to countless overlapping mental health issues. 
 
• Testing of TCT has shown it to be a safe and feasible 
adjunctive treatment in managing depression and suicidality with 
no disconcerting side effects, contrary to most medication.  
 
• Antidepressant medication may take months to produce a 
sustained effect; TCT is administered over a short, five day 
period. 
 
Figure 1. Antidepressant response. Figure above: Description 
during TCT intervention. Figure below: Longitudinal 
description at 7-day and 30-day follow up. 
 
Preliminary Results 
31 participants enrolled; 29 participants completed intervention. 
* 26 (84%) experienced a response to TCT (50% reduction in depression 
score). 
* 24 (77%) experienced remission based on Hamilton Depression Scale 
(HAMD-17). 
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